DLC-1 is an independent prognostic marker and potential therapeutic target in hepatocellular cancer

BACKGROUND: The 5-year survival rate of patients with hepatocellular cancer (HCC) was very low because of invasion and metastasis in the early stage. Biomarkers might help predict early occurrence of invasion and metastasis. Accumulating evidence has shown that deleted in liver cancer-1 (DLC1) may b...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Diagn Pathol
Asıl Yazarlar: Song, L. J., Liu, Q., Meng, X. R., Li, SH. L, Wang, L. X., Fan, Q. X., Xuan, X. Y.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2016
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4743322/
https://ncbi.nlm.nih.gov/pubmed/26846339
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13000-016-0470-x
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller